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Comment: Although pediatricians are not called on to make technical surgical decisions, we are frequently consulted by 
our patients and their families to confirm the advisability of proposed surgical intervention. Because of the complexity and 
the severity of portal vein obstruction in children, it is especially important that we understand the issues addressed in the 
two papers in this issue by Alvarez et al. and in the following commentaries. Unusually important are the issues in regard 
to early intervention and the long-term implications of dangerous hemorrhage and encephalopathy. Readers will quickly 
detect that perfect agreement has not been reached. Yet we agree with our four reviewers that the series is large, the 
results impressive, and the implications in reference to diagnosis and management significant. Accordingly, we hope that 
all physicians will find this timely, comprehensive revisitation as stimulating and as informative as we have.-R.E.M. 
Portal vein thrombosis and portal diversion 
THE ARTICLES BY ALVAREZ ET AL., in this issue of The 
Journal advocating portosystemic shunt procedures in 
children with portal vein thrombosis are certain to be 
controversial. In the United States and Canada, the 
consensus developed by pediatric surgeons during the last 
decade is that such shunt procedures are not often indi-
cated. I,2 It has been claimed that children with portal vein 
obstruction rarely bleed to death if given conservative 
treatment. However, the most important reason for a 
nonsurgical approach has been a very high incidence of 
shunt thrombosis in patients younger than 10 years old or 
if the portal vein is < 1 0 mm in diameter, 1.2 
Articles on the subject may outnumber the patients 
treated, and the personal experience of some of the authors 
has apparently been miniscule. The largest American 
series, reported by Grauer and Schwartz,3 consisted of 19 
patients, It is clear from that experience that portosystemic 
shunts can be performed in children with little fear of 
thrombosis. The importance of technical proficiency is well 
illustrated in the experience of Alvarez et al.: more than 
90% of the anastomoses apparently remained patent, 
Granting that effective operations are feasible, there are 
physiologic consequences of portal diversion that have 
become clear only recently, When a portal vein is gradual-
ly occluded in animals4 or is obstructed by thrombosis in 
humans,s the lost venous inflow to the liver is restored to a 
significant extent by hepatopetal (liver seeking) collateral 
veins, An effective portosystemic shunt "steals" this collat-
eral flow, placing the liver in the same state as that 
produced in an anatomically normal patient by a complete-
ly diverting end-to-side portacaval shunt.5 Warren et aU 
have described two patients with portal vein thrombosis 
who developed hepatic encephalopathy long after portosys-
temic shunts were established; the encephalopathy was 
relieved when the shunts were taken down. 
Completely diverting portacaval shunts cause wide-
ranging changes in the liver of rats, dogs, swine, subhuman 
primates, and humans.6 The hepatocytes undergo atrophy 
and hyperplasia, fatty infiltration, deglycogenation, and 
drastic changes in organelle structure," The most specific 
change in the organelles is depletion (with disruption) of 
the rough endoplasmic reticulum. The changes are caused 
by the diversion around the liver of the so-called hepato-
tropic factors in the portal venous blood, of which insulin is 
the most important.1 
See related articles, pp. 696, 703, and 742. 
Because the rough endoplasmic reticulum is the "facto-
ry" of the liver cell, it is not surprising that many and 
probably most hepatic synthetic processes are reduced by 
complete portal diversion. Depressions have been described 
in lipid and bile acid synthesis, the Krebs-Henseleit cycle, 
and the hepatic microsomal mixed-function enzyme sys-
tem.8 These discoveries have shown how undesirable porto-
systemic shunting is, and have emphasized that complete 
portal diversion procedures should be done only for life-
threatening indications. The 12 prophylactic portosystemic 
shunts in the 76 patients of the Alvarez series were not 
lifesaving, and may provoke unusual criticism, 
Nevertheless, the data of the French group have pro-
vided convincing evidence that the benefits of a portosys-
temic shunt exceed the risks in patients with portal vein 
thrombosis and life-threatening complications of portal 
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hypertension. The absence of encephalopathy was striking 
but in accord with experience in patients in whom the 
reason for complete diversion was an inborn error of 
metabolism. The clearest evidence has been in patients 
with familial hypercholesterolemia. The architecture of 
the liver is completely normal in this disease. Several dozen 
patients have been studied for long periods after the 
creation of completely diverting end-to-side portacaval 
shunts, and there has been only one equivocal example of 
encephalopathy,S which was effectively treated with a 
low-protein diet. 
The demonstration that portal diversion procedures can 
be done in children with a high degree of technical success 
and with a low incidence (zero in this experience) of 
consequent hepatic failure or encephalopathy may change 
the excessively conservative attitudes prevalent in North 
America. 
Thomas E. Starzl, M.D., Ph.D. 
Department of Surgery 
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Pittsburgh, PA 15261 
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